• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Board Meeting, 10-08-2026: Outcome of Board Meeting

    10-08-2026 | 01:56 pm

    AstraZeneca Pharma India Board met, approved Q1 results: Revenue soared 30% to ₹682.8 Cr, profit hit ₹50.7 Cr. Arun Krishna joined as Addl. Director; Bhavana Agrawal's role changed. Company also secured key drug approvals and launched strategic initiatives.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited